Back to Search
RUSSELL YOCUM, DO
DO
Family Medicine Physician
NPI: 1649241282IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
R3J21(MO)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Class of 1986
Research & Publications (17)
Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.
PMID 19459762·Diabetes Technol Ther·2009
3-trial
Assessing the role of human recombinant hyaluronidase in gravity-driven subcutaneous hydration: the INFUSE-LR study.
PMID 18095810·J Palliat Med·2007
2-rct
Removing a bottleneck in the Bacillus subtilis biotin pathway: bioA utilizes lysine rather than S-adenosylmethionine as the amino donor in the KAPA-to-DAPA reaction.
PMID 15880481·Biotechnol Bioeng·2005
8-other
A phase II multicenter clinical trial of systemic bexarotene in psoriasis.
PMID 15280844·J Am Acad Dermatol·2004
3-trial
9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.
PMID 12588223·Arch Dermatol·2003
3-trial
Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
PMID 14613038·Semin Oncol·2003
6-review
Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial.
PMID 14576658·J Am Acad Dermatol·2003
3-trial
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.
PMID 12637463·J Clin Oncol·2003
3-trial
Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma.
PMID 11902983·Arch Dermatol·2002
3-trial
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
PMID 11346336·Arch Dermatol·2001
3-trial
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.
PMID 11331325·J Clin Oncol·2001
3-trial
The bio operon on the acquired symbiosis island of Mesorhizobium sp. strain R7A includes a novel gene involved in pimeloyl-CoA synthesis.
PMID 11320134·Microbiology (Reading)·2001
8-other
Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials.
PMID 11309029·Australas J Dermatol·2001
3-trial
Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancer.
PMID 14700480·Clin Lung Cancer·2001
3-trial
Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
PMID 11705307·Am J Clin Dermatol·2001
3-trial
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
PMID 11115156·Arch Dermatol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2600 RUNNING HORSE ROAD
PLATTE CITY, MO 64079 - Phone
- (816) 858-2200
Quick Facts
- NPI
- 1649241282
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 17
Are you this provider?
Claim Your Profile